QCM
TBPH icon

Quantinno Capital Management’s Theravance Biopharma TBPH Stock Holding History

Quantinno Capital Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524K Buy
30,850
+12,812
+71% +$212K ﹤0.01% 2960
2026
Q1 		$293K Buy
18,038
+4,463
+33% +$79K ﹤0.01% 3045
2025
Q4 		$254K Buy
13,575
+1,352
+11% +$22.4K ﹤0.01% 2932
2025
Q3 		$178K Buy
+12,223
New +$154K ﹤0.01% 2793

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Quantinno Capital Management's TBPH Position: Q2 2026 in Review

Quantinno Capital Management increased its Theravance Biopharma (TBPH) stake by 71% in Q2 2026, buying an estimated $212K and bringing the position to 30,850 shares worth $524K. The position accounts for ﹤0.01% of the portfolio, ranked #2960.

Quantinno Capital Management first reported a position in TBPH in Q3 2025 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Quantinno Capital Management held 30,850 shares of Theravance Biopharma worth $524K as of Q2 2026.
  • Quantinno Capital Management bought 12,812 Theravance Biopharma shares in Q2 2026, an estimated $212K.
  • Theravance Biopharma made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2960 holding.
  • Quantinno Capital Management first reported a position in Theravance Biopharma in Q3 2025 and has held it in 4 quarters since.
  • 180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.